(MedPage Today) — The FDA approved semaglutide (Ozempic) to reduce the risk of kidney disease worsening, kidney failure, and death due to cardiovascular disease in adults with type 2 diabetes and chronic kidney disease (CKD), making it the only…
Source link : https://www.medpagetoday.com/nephrology/diabetes/113985
Author :
Publish date : 2025-01-28 21:45:15
Copyright for syndicated content belongs to the linked Source.
